1. Home
  2. ATNM vs SNT Comparison

ATNM vs SNT Comparison

Compare ATNM & SNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Actinium Pharmaceuticals Inc. (Delaware)

ATNM

Actinium Pharmaceuticals Inc. (Delaware)

SELL

Current Price

$0.97

Market Cap

37.1M

Sector

Health Care

ML Signal

SELL

Logo Senstar Technologies Ltd.

SNT

Senstar Technologies Ltd.

SELL

Current Price

$1.40

Market Cap

35.9M

ML Signal

SELL

Company Overview

Basic Information
Metric
ATNM
SNT
Founded
2000
1965
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
37.1M
35.9M
IPO Year
2013
2023

Fundamental Metrics

Financial Performance
Metric
ATNM
SNT
Price
$0.97
$1.40
Analyst Decision
Buy
Analyst Count
4
0
Target Price
★ $3.60
N/A
AVG Volume (30 Days)
★ 98.9K
13.9K
Earning Date
11-13-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 14.17
N/A
EPS
★ 0.71
N/A
Revenue
★ $90,000.00
N/A
Revenue This Year
$19,344.45
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ $1.41
$19.22
Revenue Growth
★ 11.11
N/A
52 Week Low
$0.74
$1.42
52 Week High
$1.74
$5.34

Technical Indicators

Market Signals
Indicator
ATNM
SNT
Relative Strength Index (RSI) 34.56 31.12
Support Level $0.88 N/A
Resistance Level $1.13 $1.67
Average True Range (ATR) 0.07 0.08
MACD -0.03 -0.01
Stochastic Oscillator 1.27 0.00

Price Performance

Historical Comparison
ATNM
SNT

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.

About SNT Senstar Technologies Ltd.

Senstar Technologies Corp is an international provider of comprehensive physical, video, and access control security products and solutions. The company offers comprehensive solutions for critical sites, which leverage its broad portfolio of homegrown PIDS (Perimeter Intrusion Detection Systems), advanced VMS and SMS (Video Management Software and Security Management Software) with native IVA (Intelligent Video Analytics) security solutions, as well as access control products and technologies. Geographically, the company operates in North America, which derives maximum revenue; Europe; APAC; South and Latin America; and Others.

Share on Social Networks: